AOB Postdoc Freddy Nguyen's venture, Nine Diagnostics, selected for Merck Digital Sciences Studio

Nine Diagnostics was accepted into the latest cohort of the Merck Digital Sciences Studio (MDS Studio), a digital accelerator designed to enable the next generation of technologies for drug discovery and development, including artificial intelligence and machine learning. MDS Studio was founded to offer support for early-stage biomedical startups providing strategic guidance, direct investment, and connection opportunities within Merck.

Nine Diagnostics developed a proprietary platform designed to analyze biological samples at the molecular level, utilizing fluorescent nanosensors to identify changes indicative of disease states or therapeutic responses. This capability provides clinicians with real-time, granular biological data, enabling a more precise understanding of individual health profiles. Congratulations, Freddy!